Alterations of enteric mucosal mast cells in patients with irritable bowel syndrome

World Chinese Journal of Digestology

Volumn 12, Issue 2, 2004, Pages 382-384

  Wang, Jing ^a   Liang, Lie Xing ^a   Zhang, Zhi Xiong ^b   Li, Guo Hua ^c   Qian, Wei ^a   Hou, Xiao Hua ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b People's Hospital   (China)

^c JIANGXI MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CECUM; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; COLONOSCOPY; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; MAST CELL; MAST CELL DEGRANULATION; PATHOGENESIS; RECTUM; TRANSVERSE COLON; VOLUNTEER;

EID: 1942473876     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v12.i2.382     Document Type: Article

References (18)

1. Wood JD. Neuropathophysiology of irritable bowel syndrome. J Clin Gastroenterol 2002;35(1 Suppl):S11-22
2. Camilleri M, Heading RC, Thompson WG. Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther 2002;16:1407-1430
3. Hasler WL. The irritable bowel syndrome. Med Clin North Am 2002;86:1525-1551
4. Bodemar G, Ragnarsson G. Irritable bowel syndrome. Survey of definitions, differential diagnosis and pathogenesis. Lakartidningen 2001;98:666-671
5. Elsenbruch S, Orr WC. Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses. Am J Gastroenterol 2001;96:460-466
6. Hebden JM, Blackshaw E, D'Amato M, Perkins AC, Spiller RC. Abnormalities of GI transit in bloated irritable bowel syndrome: effect of bran on transit and symptoms. Am J Gastroenterol 2002;97:2315-2320
7. Chey WY, Jin HO, Lee MH, Sun SW, Lee KY. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol 2001; 96:1499-1506
8. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000;95:3503-3506
9. Bouin M, Delvaux M, Blanc C, Lagier E, Delisle MB, Fioramonti J, Bueno L, Frexinos J. Intrarectal injection of glycerol induces hypersensitivity to rectal distension in healthy subjects without modifying rectal compliance. Eur J Gastroenterol Hepatol 2001;13:573-580
10. Zar S, Kumar D, Kumar D. Role of food hypersensitivity in irritable bowel syndrome. Minerva Med 2002;93:403-412
11. O'Sullivan M, Clayton N, Breslin NP, Harman I, Bountra C, McLaren A, O'Morain CA. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil 2000;12:449-457
12. Neal KR, Barker L, Spiller RC. Prognosis in post-infective irritable bowel syndrome: a six year follow up study. Gut 2002; 51:410-413
13. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-811
14. Locke GR 3rd, Zinmeister AR, Talley NJ, Fett SL, Melton LJ. Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol 2000;95:157-165